Inj. cefepime hcl (baxter)
Products billed under this code include Cefepime HCl.
Payment limit per 500 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Cefepime HCl.
Payment limit per 500 MG, by effective quarter, 1Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cefepime HCl | Baxter Healthcare Corporation | 00338-1301-41 | 48 | $292.608 |
| Cefepime HCl | Baxter Healthcare Corporation | 00338-1301-48 | 48 | $292.608 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $6.096 | +$0.069 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted September 17, 2026 |
| 3Q26 | $6.027 | +$0.119 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted September 15, 2026 |
| 2Q26 | $5.908 | −$0.062 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted September 15, 2026 |
| 1Q26 | $5.97 | −$0.075 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted September 15, 2026 |
| 4Q25 | $6.045 | +$0.174 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted September 8, 2026 |
| 3Q25 | $5.871 | +$0.067 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted March 10, 2026 |
| 2Q25 | $5.804 | +$0.067 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted March 10, 2026 |
| 1Q25 | $5.737 | −$0.096 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted December 19, 2025 |
| 4Q24 | $5.833 | +$0.139 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted June 11, 2025 |
| 3Q24 | $5.694 | −$0.066 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted June 11, 2025 |
| 2Q24 | $5.76 | +$0.123 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted March 11, 2025 |
| 1Q24 | $5.637 | −$0.051 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted December 19, 2024 |
| 4Q23 | $5.688 | −$0.03 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted October 10, 2024 |
| 3Q23 | $5.718 | +$0.359 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted June 5, 2024 |
| 2Q23 | $5.359 | −$0.072 | 500 MG | Inj. cefepime hcl (baxter) | v1, posted February 23, 2024 |
| 1Q23 | $5.431 | – | 500 MG | Inj. cefepime hcl (baxter) | v1, posted December 6, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.